Strategic Advisors LLC Astrazeneca PLC Transaction History
Strategic Advisors LLC
- $609 Million
- Q3 2025
A detailed history of Strategic Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Strategic Advisors LLC holds 3,481 shares of AZN stock, worth $311,201. This represents 0.04% of its overall portfolio holdings.
Number of Shares
3,481
Previous 3,480
0.03%
Holding current value
$311,201
Previous $243,000
9.88%
% of portfolio
0.04%
Previous 0.05%
Shares
7 transactions
Others Institutions Holding AZN
# of Institutions
1,497Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...